Perspectives and practices of ototoxicity monitoring
Background: Treatment of cancer with cisplatin can result in hearing loss. Given the increasing burden of cancer in Africa, appropriate and timely identification, intervention and management of hearing loss in affected patients is of paramount importance. Objectives: This study describes the perspe...
Main Authors: | Jessica Paken, Cyril D. Govender, Mershen Pillay, Vikash Sewram |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2020-05-01
|
Series: | South African Journal of Communication Disorders |
Subjects: | |
Online Access: | https://sajcd.org.za/index.php/sajcd/article/view/685 |
Similar Items
-
Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa
by: Jessica Paken, et al.
Published: (2021-07-01) -
Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting
by: Jessica Paken, et al.
Published: (2022-06-01) -
Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity
by: Jessica Paken, et al.
Published: (2021-04-01) -
High incidence of cisplatin-induced ototoxicity in paediatric patients in the Western Cape, South Africa
by: Mukovhe Phanguphangu, et al.
Published: (2018-07-01) -
Cisplatin-Associated Ototoxicity: A Review for the Health Professional
by: Jessica Paken, et al.
Published: (2016-01-01)